Nonequilibrium Colloids: Temperature-Induced Bouquet Formation of Flower-like Micelles as a Time-Domain-Shifting Macromolecular Heat Alert

Climate change requires enhanced autonomous temperature monitoring during logistics/transport. A cheap approach comprises the use of temperature-sensitive copolymers that undergo temperature-induced irreversible coagulation. The synthesis/characterization of pentablock copolymers (PBCP) starting from poloxamer PEO130-b-PPO44-b-PEO130 (poly(ethylene oxide)130-b-poly(propylene oxide)44-b-poly(ethylene oxide)130) and adding two terminal qPDMAEMA85 (quaternized poly[(2-dimethylamino)ethyl methacrylate]85) blocks is presented. Mixing of PBCP solutions with hexacyanoferrate(III)/ferricyanide solutions leads to a reduction of the decane/water interfacial tension accompanied by a co/self-assembly toward flower-like micelles in cold water because of the formation of an insoluble/hydrophobic qPDMAEMA/ferricyanide complex. In cold water, the PEO/PPO blocks provide colloidal stability over months. In hot water, the temperature-responsive PPO block is dehydrated, leading to a pronounced temperature dependence of the oil-water interfacial tension. In solution, the sticky PPO segments exposed at the micellar corona cause a colloidal clustering above a certain threshold temperature, which follows Smoluchowski-type kinetics. This coagulation remains for months even after cooling, indicating the presence of a kinetically trapped nonequilibrium state for at least one of the observed micellar structures. Therefore, the system memorizes a previous suffering of heat. This phenomenon is linked to an exchange of qPDMAEMA-blocks bridging the micellar cores after PPO-induced clustering. The addition of ferrous ions hampers the exchange, leading to the reversible coagulation of Prussian blue loaded micelles. Hence, the Fe2+ addition causes a shift from history monitoring to the sensing of the present temperature. Presumably, the system can be adapted for different temperatures in order to monitor transport and storage in a simple way. Hence, these polymeric "flowers" could contribute to preventing waste and sustaining the quality of goods (e.g., food) by temperature-induced bouquet formation, where an irreversible exchange of "tentacles" between the flowers stabilizes the bouquet at other temperatures as well.

Liquid-liquid phase separated microdomains of an amphiphilic graft copolymer in a surfactant-rich medium

The liquid-liquid phase separation (LLPS) of amphiphilic thermoresponsive copolymers can lead to the formation of micron-sized domains, known as simple coacervates. Due to their potential to confine active principles, these copolymer-rich droplets have gained interest as encapsulating agents. Understanding and controlling the conditions inducing this LLPS is therefore essential for applicative purposes and requires thorough fundamental studies on self-coacervation. In this work, we investigate the LLPS of a comb-like graft copolymer (PEG-g-PVAc) consisting of a poly(ethylene glycol) backbone (6 kDa) with ∼2-3 grafted poly(vinyl acetate) chains, and a PEG/PVAc weight ratio of 40/60. Specifically, we report the effect of various water-soluble additives on its phase separation behavior. Kosmotropes and non-ionic surfactants were found to decrease the phase separation temperature of the copolymer, while chaotropes and, above all, ionic surfactants increased it. We then focus on the phase behavior of PEG-g-PVAc in the presence of sodium citrate and a C_14-15 E₇ non-ionic surfactant (N45-7), defining the compositional range for the generation of LLPS microdomains at room temperature and monitoring their formation with fluorescence confocal microscopy. Finally, we determine the composition of the microdomains through confocal Raman microscopy, demonstrating the presence of PEG-g-PVAc, N45-7, and water. These results expand our knowledge on polymeric self-coacervation, clarifying the optimal conditions and composition needed to obtain LLPS microdomains with encapsulation potential at room temperature in surfactant-rich formulations.

Micellar buccal film for safe and effective control of seizures: Preparation, in vitro characterization, ex vivo permeation studies and in vivo assessment

The current research article focused on formulating an easily applied, water-based buccal film loaded with the antiepileptic drug, lamotrigine (LTG). The designed film can be comfortably administered by epileptic patients to ensure a controllable therapeutic efficacy against seizures. The solubility of LTG in water was significantly improved by micellar solubilization. Upon testing several surfactants, three of them (Synperonic PE/P84, Brij L23, and Brij 78) achieved maximum possible solubility for LTG and were characterized for their micellar size, cloud point, and % transmittance. Selected micellar systems were incorporated within a buccal film prepared using solvent casting method based on either gelatin or polyvinylpyrrolidone (3%w/v) with 1.5%w/v propylene glycol as a plasticizer. Different micellar films were characterized for their physicochemical characteristics, swelling index, folding endurance, drug content uniformity, and in vitro LTG release. From the tested formulations, one formulation; LTG-BF1 (in which Brij 78 was used for the micellar solubilization and gelatin as the matrix former), was selected as the optimum and extensively studied for mucoadhesion, ex vivo permeation studies by Franz diffusion cells and confocal laser scanning microscopy. Results showed superior enhanced permeation of micellar film. LTG-BF1 was evaluated for the in vivo performance using rats. Status epilepticus was induced in rats by injecting Pentylenetetrazol (PTZ) i.p. at an initial dose of 30 mg/kg, followed by 10 mg/kg every10 min till 60 min. A group of rats receiving the designed buccal formulation (20 mg/kg) was compared with a group receiving the same dose of the oral market product and the normal control and PTZ groups. Rats receiving LTG-BF1 recorded reduced seizure scores at all stages, longer latency time, and higher threshold PTZ dose compared to PTZ and market product groups. In addition, LTG-BF1 reduced brain concentrations of TNF-α and TGF-β with an elevation of EAAT2 and GABA brain contents compared to PTZ and market product groups and ameliorated neuronal damage. In conclusion, LTG-loaded buccal micellar film proved a superior antiepileptic effect in PTZ induced acute epileptic model.

Formulation, Solubilization, and In Vitro Characterization of Quercetin-Incorporated Mixed Micelles of PEO-PPO-PEO Block Copolymers

Quercetin (QCN) is a plant polyphenol with a variety of medicinal effects. Poor water solubility, on the other hand, restricts its therapeutic effectiveness. The purpose of this study was to develop mixed micellar systems using two biocompatible amphiphilic PEO-PPO-PEO triblock copolymers, Pluronic P123 (EO₂₀-PO₇₀-EO₂₀) and Pluronic F88 (EO₁₀₄-PO₃₉-EO₁₀₄), in order to enhance the aqueous solubility and oral bioavailability of QCN drug. The critical micelle concentrations (CMCs) of mixed P123/F88 micellar solutions were investigated using UV-visible spectroscopy with pyrene as a probe. Mixed P123/F88 micelles have low CMCs, indicating that they have a stable micelle structure even when diluted. The solubility of QCN in aqueous mixed P123/F88 micellar solutions at different temperatures was investigated to better understand drug entrapment. The QCN solubility increased with increasing temperature in the mixed P123/F88 micellar system. The QCN-incorporated mixed P123/F88 micelles were prepared using the thin-film hydration method and were well characterized in terms of size and morphology, compatibility, in vitro release and antioxidant profile. In addition, the cell proliferation activity of the mixed micelles was evaluated in the MCF-7 cell line. The QCN-incorporated mixed P123/F88 micelles had a small particle size (< 25 nm) and a negative zeta potential with a spherical shape. The in vitro release behaviour of QCN from a mixed P123/F88 micellar system was slower and more sustained at physiological conditions. The oxidation resistance of QCN-incorporating mixed P123/F88 micelles was shown to be considerably higher than that of pure QCN. An in vitro cell proliferation study revealed that QCN-incorporated mixed micells were effective in inhibiting tumour cell growth. In conclusion, the QCN-incorporated mixed P123/F88 micelle may be a promising approach to increase QCN oral bioavailability, antioxidant activity, and cell viability.

Impact of salts on the phase separation and thermodynamic properties of mixed nonionic surfactants in absence/attendance of polyvinyl alcohol

Mixed surfactant systems are used in different applied fields like pharmaceutical formulation rather than single surfactant. Therefore, the determination of the clouding nature of the triton X-100 (TX-100) + Tween 80 (TW-80) mixture was carried out in H2O and polyvinyl alcohol (PVA). In the occurrence of PVA, the cloud point (CP) values of TX-100 initially enhance with enhancing the concentration of PVA and tend to decrease after a certain concentration. For different ratios of TX-100 and TW-80 mixture having the same concentration of both solutions, CP values increase through the decreasing ratios of TX-100 with/without PVA. In the presence of polymer, at higher ratios of TX-100 than TW-80, the CP values are higher in magnitudes in comparison to the aqueous medium but at lower ratios of TX-100, the value of CP are lower in magnitudes in comparison to the aqueous system. The CP values of the TX-100 + TW-80 mixture in the salt system are lower in magnitudes than the aqueous medium in both the absence/presence of PVA. However, a reduction of CP values was obtained to a large extent for Na2SO4 over NaCl in the case of lower volume ratios of TX-100. Various thermodynamic variables (standard free energy ( Δ G c o ${\Delta}{G}_{c}^{o}$ ), standard enthalpy ( Δ H c o ${\Delta}{H}_{c}^{o}$ ), standard entropy ( Δ S c o ${\Delta}{S}_{c}^{o}$ ) change, thermodynamic parameters of transfer (free energy of transfer ( Δ G c , t o ${\Delta}{G}_{c,t}^{o}$ ), and transfer of enthalpies ( Δ H c , t o ${\Delta}{H}_{c,t}^{o}$ )) of phase transition) were also determined.

Clouding phenomenon in amphiphilic systems: A review of five decades

Phase separation in amphiphilic systems is an important phenomenon. The temperature at which an amphiphilic solution phase separates is known as Cloud Point (CP). This article reviews in detail the process of phase separation in various amphiphiles (surfactants, polymers and drugs) and effect of different classes of additives on the CP of these amphiphilic systems. Ions affect the CP of drugs in a different way: kosmotropes and hard bases decrease while chaotropes and soft bases increase the CP of nonionic and cationic surfactants. Anionic surfactants show CP in presence of quaternary salts only. Thus, depending upon the nature and concentration of additive, the CP of an amphiphilic system gets increased or decreased and, hence, properties of the system may be tuned as per the need and use. A system with CP at high concentration can be made to phase separate at lower concentration by simply introducing an appropriate additive in it. This makes the system cost effective. On the other hand, if not required, a low CP can be enhanced with the help of another type of a suitable additive.

Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil®

Doxorubicin (DOX) is used as a "first-line" antineoplastic drug in ovarian and metastatic breast cancer. However, serious side effects, such as cardiotoxicity have been reported after DOX intravenous administration. Hence, we investigated different micelle-former biomaterials, as Soluplus^®, Pluronic F127, Tetronic T1107 and d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) to develop a potential mixed micellar nanocarrier for DOX delivery. Since DOX hydrochloride is a poor candidate to be encapsulated inside the hydrophobic core of the mixed micelles, we assayed a hydrophobic complex between DOX and sodium deoxycholate (NaDC) as an excellent candidate to be encapsulated within polymeric micelles. The combination of T1107:TPGS (1:3, weight ratio) demonstrated the best physicochemical properties together with a high DL capacity (6.43% w/v). Particularly, DOX in vitro release was higher at acidic tumour microenvironment pH value (5.5) than at physiological counterpart (7.4). The hydrodynamic diameter of the DOX/NaDC-loaded mixed micellar system was 10.7nm (PDI=0.239). The in vitro cytotoxicity of the mixed micellar formulation resulted significantly (p<0.05) higher than Doxil^® against ovarian (SKOV-3) and triple-negative breast cancer cells (MDA-MB- 231). Further, the in vitro cellular uptake assays demonstrated a significant increment (p<0.05) of the DOX intracellular content for the mixed micelles versus Doxil^® for both, SKOV-3 (at 2, 4 and 6h of incubation) and MDA-MB-231 (at 4h of incubation) cells. These findings suggest that T1107:TPGS (1:3) mixed micelles could be employed as a potential nanotechnological platform for drug delivery of DOX.

Tri/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation

Polymeric micelles that can deliver drug to intended sites of the eye have attracted much scientific attention recently. The aim of this study was to evaluate the aqueous-based formulation of drug-loaded polymeric micelles that hold significant promise for ophthalmic drug delivery. This study investigated the synergistic performance of mixed polymeric micelles made of linear and branched poly(ethylene oxide)-poly(propylene oxide) for the more effective encapsulation of lornoxicam (LX) as a hydrophobic model drug. The co-micellization process of 10% binary systems combining different weight ratios of the highly hydrophilic poloxamers; Synperonic(®) PE/P84, and Synperonic(®) PE/F127 and the hydrophobic poloxamine counterpart (Tetronic(®) T701) was investigated by means of photon correlation spectroscopy and cloud point. The drug-loaded micelles were tested for their solubilizing capacity towards LX. Results showed a sharp solubility increase from 0.0318 mg/mL up to more than 2.34 mg/mL, representing about 73-fold increase. Optimized formulation was selected to achieve maximum drug solubilizing power and clarity with lowest possible particle size, and was characterized by (1)HNMR analysis which revealed complete encapsulation of the drug within the micelles. Further investigations by histopathological and confocal laser studies revealed the non-irritant nature and good corneal penetrating power of the proposed nano-formulation.

Interaction, solubilization and location of p-hydroxybenzoic acid and its sodium salt in micelles of moderately hydrophilic PEO-PPO-PEO triblock copolymers

Micelles of ABA type triblock copolymers (where A is polyethylene oxide PEO and B is polypropylene oxide PPO) viz. Pluronic® P103, P104 and P105 (each containing almost the same PPO mol wt. ~ 3250 g/mol and 30, 40 and 50 wt.% of PEO, respectively) in the presence of p -hydroxybenzoic acid (PHBA) and its sodium salt (Na-PHBA) were examined by viscosity, dynamic light scattering (DLS), small angle neutron scattering (SANS) and NMR. Spherical polymeric micelles (apparent hydrodynamic diameter ~ 20 nm) in water at 30 °C grow in the presence of PHBA and transform into prolate-ellipsoidal shape with an increased aggregation number. The micellar transition was favored at higher PHBA concentration, temperature and for copolymers with more hydrophobicity. The PHBA salt, however, increased cloud point and showed only a marginal decrease in aggregation number even at much higher concentrations. The location of PHBA in micelle was elucidated by nuclear Overhauser enhancement spectroscopy (NOESY).

Clouding and Aggregation Behavior of PPO-PEO-PPO Triblock Copolymer (Pluronic®25R4) in Surfactant Additives Environment

Aqueous solutions of commercially available Pluronic®R i. e. triblock copolymer composed of polypropylene oxide(PPO)-polyethylene oxide(PEO)-polypropylene oxide(PPO), (code named 25R4, BASF) in the presence of surfactant additives viz. hydrotropes (NaTS, NaXS), anionics (SDS, SDBS) and cationics (DTAB, CTAB) were investigated by cloud point(CP), surface tension and conductance techniques. All the techniques clearly indicated that Pluronic®25R4 interacts strongly with anionic surfactants but weakly with cationic surfactants. Surfactant additives used here, produced a marked increase in the CP of the copolymer. Elevation in CP is attributed to the solubility of PPO block of the copolymer and formation of Pluronic-surfactant complex. The effect of NaCl salt on the CP of Pluronic®25R4 at added SDS and CTAB was also studied and it was decreased due to the screening effect. At the presence of 25R4 in its non-associated form, the surface tension and conductance data is discussed with binding process and indicated strong interaction of Pluronic®25R4 with SDS, showing two break points (P1 and P2) in the plot and very weak interaction with CTAB observing single break point.

Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy

Polymeric micelles of single and mixed poloxamines (Tetronic) were evaluated regarding their ability to host the antiglaucoma agent ethoxzolamide (ETOX) for topical ocular application. Three highly hydrophilic varieties of poloxamine (T908, T1107 and T1307) and a medium hydrophilic variety (T904), possessing a similar number of propylene oxide units but different contents in ethylene oxide, were chosen for the study. The critical micellar concentration and the cloud point of mixed micelles in 0.9 per cent NaCl were slightly greater than the values predicted from the additive rule, suggesting that the co-micellization is hindered. Micellar size ranged between 17 and 120 nm and it was not altered after the loading of ETOX (2.7-11.5 mg drug g(-1) poloxamine). Drug solubilization ability ranked in the order: T904 (50-fold increase in the apparent solubility) > T1107 is approximately equal to T1307 > T908. Mixed micelles showed an intermediate capability to host ETOX but a greater physical stability, maintaining almost 100 per cent drug solubilized after 28 days. Furthermore, the different structural features of poloxamines and their combination in mixed micelles enabled the tuning of drug release profiles, sustaining the release in the 1-5 days range. These findings together with promising hen's egg test-chorioallantoic membrane biocompatibility tests make poloxamine micelles promising nanocarriers for carbonic anhydrase inhibitors in the treatment of glaucoma.

Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles

This study investigated the synergistic performance of mixed polymeric micelles made of linear and branched poly(ethylene oxide)-poly(propylene oxide) for the more effective encapsulation of the anti-HIV drug efavirenz. The co-micellization process of 10% binary systems combining different weight ratios of a highly hydrophilic poloxamer (Pluronic F127) and a more hydrophobic poloxamine counterpart (Tetronic T304 and T904) was investigated by means of dynamic light scattering, cloud point and electronic spin resonance experiments. Then, the synergistic solubilization capacity of the micelles was shown. Findings revealed a sharp solubility increase from 4 μg/ml up to more than 33 mg/ml, representing a 8430-fold increase. Moreover, the drug-loaded mixed micelles displayed increased physical stability over time in comparison with pure poloxamine ones. Overall findings confirmed the enormous versatility of the poloxamer/poloxamine systems as Trojan nanocarriers for drug encapsulation and release by the oral route and they entail a relevant enhancement of the previous art towards a more compliant pediatric HIV pharmacotherapy.

Physical characterization and in vivo evaluation of poloxamer-based DNA vaccine formulations

BACKGROUND

Plasmid DNA (pDNA) vaccines have generated significant interest for the prevention or treatment of infectious diseases. Broader applications may benefit from the identification of safe and potent vaccine adjuvants. This report describes the development of a novel polymer-based formulation to enhance the immunogenicity of pDNA-based vaccines.

METHODS

Plasmid DNA was formulated with a nonionic block copolymer, poloxamer CRL1005, and the cationic surfactant benzalkonium chloride (BAK) to produce a thermodynamically stable, self-assembling system. The influence of parameters such as polymer concentration and BAK composition on the immune responses was evaluated in mice vaccinated with pDNA encoding influenza nucleoprotein.

RESULTS

At concentrations of 7.5 mg/ml CRL1005, 0.3 mM BAK and 5 mg/ml pDNA, CRL1005/BAK/pDNA particles had a mean diameter of 261 +/- 0.2 nm and a surface charge of - 11.6 +/- 0.9 mV. The negative surface charge and atomic force microscopy images suggested that pDNA binds to BAK adsorbed to the surface of poloxamer particles. The CRL1005/BAK/pDNA formulation significantly enhanced antigen-specific cellular and humoral immune responses, and increased transgene levels in muscle and serum. The complexity of the formulation was reduced by replacing the commercial BAK, which is a mixture of four alkyl chains, with a C14 BAK homolog. The substitution yielded an analytically preferable formulation with equivalent physical characteristics and immunogenicity.

CONCLUSIONS

The results suggest that the CRL1005/BAK/pDNA formulation may enhance immunogenicity by improving the delivery of pDNA-based vaccines. This formulation is currently being evaluated for the prevention of CMV-associated disease in a phase 2 clinical trial.